跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 3,724 条关于
“inorganic pyrophosphate (PPi)”
全部
3,724
临床试验
2,886
药物
606
机构
26
资讯
206
上个月
BioMarin to Acquire Alesta Therapeutics for ALE1, a Potential First Oral Therapy for Hypophosphatasia
4个月前
BioMarin's BMN 401 Shows Mixed Results in Phase 3 Trial for Rare ENPP1 Deficiency
去年
Recursion Pharmaceuticals Acquires Full Rights to REV102, Potential First-in-Class Oral ENPP1 Inhibitor for Hypophosphatasia
去年
Be Biopharma to Present Promising Nonclinical Data for Novel B Cell Therapy in Hypophosphatasia Treatment
去年
PROPHECI Trial Launches to Test Pyrophosphate Treatment for Rare Calcification Disorder PXE
去年
Tegoprazan Outperforms Standard PPI Therapy in Phase 3 GERD Trials
2个月前
Protinah Signs PPI Biomarker Analysis Agreement with U.S. Multinational Pharma for Neurodegenerative Drug Development
上个月
BioMarin acquires Alesta Therapeutics and its hypophosphatasia drug ALE1 in $275M deal
10个月前
Akums Drugs Secures 20-Year Patent for Dual-Release PPI Technology Targeting GERD Treatment
去年
Inozyme's INZ-701 Shows Promise in ENPP1 Deficiency Trial with Sustained Phosphate Increases
第 1 页，共 21 页
上一页
下一页
